WO2003101377A3 - Association des polymorphismes mononucleotidiques dans le locus dgcr2 et les locus voisins avec la schizophrenie - Google Patents
Association des polymorphismes mononucleotidiques dans le locus dgcr2 et les locus voisins avec la schizophrenie Download PDFInfo
- Publication number
- WO2003101377A3 WO2003101377A3 PCT/IL2003/000464 IL0300464W WO03101377A3 WO 2003101377 A3 WO2003101377 A3 WO 2003101377A3 IL 0300464 W IL0300464 W IL 0300464W WO 03101377 A3 WO03101377 A3 WO 03101377A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- schizophrenia
- dgcr2
- locus
- snps
- association
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003231897A AU2003231897A1 (en) | 2002-06-03 | 2003-06-03 | Association of snps in the dgcr2 locus and neighboring loci with schizophrenia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38441302P | 2002-06-03 | 2002-06-03 | |
US60/384,413 | 2002-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003101377A2 WO2003101377A2 (fr) | 2003-12-11 |
WO2003101377A3 true WO2003101377A3 (fr) | 2005-01-27 |
Family
ID=29712028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2003/000464 WO2003101377A2 (fr) | 2002-06-03 | 2003-06-03 | Association des polymorphismes mononucleotidiques dans le locus dgcr2 et les locus voisins avec la schizophrenie |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003231897A1 (fr) |
WO (1) | WO2003101377A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090281090A1 (en) * | 2004-06-04 | 2009-11-12 | Novartis Ag | Biomarkers for the prediction of responsiveness to clozapine treatment |
EP2570501A3 (fr) * | 2008-01-02 | 2013-04-10 | Suregene Llc | Marqueurs génétiques de maladie mentale |
EP2581459A3 (fr) * | 2008-01-17 | 2013-07-17 | Suregene LLC | Marqueurs génétiques de maladie mentale |
US7932042B1 (en) | 2010-10-13 | 2011-04-26 | Suregene, Llc | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
-
2003
- 2003-06-03 AU AU2003231897A patent/AU2003231897A1/en not_active Abandoned
- 2003-06-03 WO PCT/IL2003/000464 patent/WO2003101377A2/fr not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
DATABASE SNP [online] 9 June 2004 (2004-06-09), accession no. NCBI Database accession no. rs807759 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003231897A8 (en) | 2003-12-19 |
WO2003101377A2 (fr) | 2003-12-11 |
AU2003231897A1 (en) | 2003-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006063704A3 (fr) | Polymorphisme a simple nucleotide (snp) | |
WO2003070082A3 (fr) | Utilisation de polymorphismes de nucleotides simples dans le locus comt et dans les loci voisins pour determiner une predisposition a la schizophrenie, au trouble bipolaire, au cancer du sein et au cancer colorectal | |
AU2003299817A8 (en) | Genetic polymorphisms associated with stenosis, methods of detection and uses thereof | |
WO2009059317A3 (fr) | Prédiction d'amd avec snps à l'intérieur ou près de c2, facteur b, plekha1, htra1, prelp ou loc387715 | |
AU2003257110A1 (en) | Polymorphisms for predicting disease and treatment outcome | |
WO2003065000A3 (fr) | Procedes de validation de snp et de compilation de banques de dosages | |
WO2007045197A3 (fr) | Profils d'expression destines a la prevision d'etats septiques | |
AU2003233451A1 (en) | Targets, methods, and reagents for diagnosis and treatment of schizophrenia | |
WO2003038123A3 (fr) | Procede de traitement du diabete et conditions apparentees basees sur des polymorphismes dans le gene tcf1 | |
IL166466A0 (en) | Methods for the treatment of dementia based on apoe genotype | |
AU2003201817A1 (en) | Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats | |
WO2002072604A3 (fr) | Genes et polymorphismes associes a une maladie cardiovasculaire et leur utilisation | |
WO2006063703A8 (fr) | Polymorphisme a simple nucleotide (snp) | |
WO2004043232A3 (fr) | Methodes servant a identifier des risques de melanomes et traitements correspondant | |
WO2005112568A3 (fr) | Marqueurs haplotypes et procedes d'utilisation de ceux-ci pour determiner la reponse a un traitement | |
EP1685149A4 (fr) | Amorces, procedes et trousses pour la detection d'alleles de recepteur kir | |
WO2003101377A3 (fr) | Association des polymorphismes mononucleotidiques dans le locus dgcr2 et les locus voisins avec la schizophrenie | |
WO2005072152A3 (fr) | Marqueurs genetiques apoc1 associes a la periode d'apparition de la maladie d'alzheimer | |
AU1922801A (en) | Genomic polymorphism for predicting therapeutic response | |
HK1042523A1 (zh) | 青光眼和有關疾病的核酸、工具和其診斷、預後和治療的方法 | |
WO2003054143A3 (fr) | Genes et polymorphismes sur le chromosome 10, associes a la maladie d'alzheimer et a d'autres maladies neurodegeneratives | |
AU2003299867A1 (en) | Method for single nucleotide polymorphism detection | |
FR2798138B1 (fr) | Clonage, expression et caracterisation du gene spg4 responsable de la forme la plus frequente de paraplegie spastique autosomique dominante | |
WO2005042706A3 (fr) | Marqueurs genetiques ephx2 associes a la reaction a la galantamine | |
WO2003023063A1 (fr) | Methode d'estimation du risque d'apparition de diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |